Strategic Healthcare Collaborations’ Post

Advancements in technology are revolutionizing the way we combat diseases. Cutting-edge gene-editing techniques and personalized cell therapies are harnessing the power of our own cells to tackle health challenges in ways we never thought possible. With technology propelling us towards groundbreaking therapies, the possibilities are limitless. What do you believe the future of medicine will look like? #healthtech #personalizedmedicine #celltherapy

A projected 8% increase in healthcare costs is staggering, especially for employers and patients who are already feeling this pressure. Similar to the findings in PwC's report in July, the Business Group on Health found that these rising costs are largely due to the skyrocketing cost of specialty drugs and treatments, particularly GLP-1s and gene therapies. At Proactive MD, we’re tackling the rising cost of care by focusing on prevention, chronic care management, and Patient Advocacy—helping to reduce expensive interventions and improve outcomes. We’re solving for a better way forward, bending the cost curve while keeping patients healthier. https://lnkd.in/eg5FypJC #AdvancedPrimaryCare #HealthcareSolutions #PatientAdvocacy

Missed Our Hot Topics in Employer Stop Loss Webinar? Watch it On-Demand! Did you miss our insightful webinar on the latest trends and challenges in employer stop loss? Don't worry—you can still catch up by watching the recording on-demand! In this presentation, you'll learn about: 🔹 The impact of COVID-19 on mortality and morbidity 🔹 Current medical trends affecting the general economy 🔹 Emerging insights into long COVID and its implications 🔹 The effects of Mental Health Parity on stop loss 🔹 Trends in specialty drugs and their impact 🔹 How cell and gene therapy are influencing stop-loss 🔹 The effects of deductible leveraging in stop loss 🔹 The impact of accelerating large stop-loss claims on trends 🔹 A brief history of universal healthcare 🔹 What the future holds for employer stop loss This comprehensive webinar is packed with expert insights that will help you navigate the world of employer-stop loss and be able to anticipate future challenges. Take advantage of this opportunity to stay informed and ahead of the curve. Watch the webinar on-demand now: https://lnkd.in/gS44Bxnc #EmployerStopLoss #InsuranceTrends #HealthcareInnovation #Covid19Impact #SpecialtyDrugs #MentalHealthParity #StopLossClaims #TFinsurance

🔔 Only a few weeks left to get early bird discount. This is the place to be, to learn about #Cell and #genetherapy and how existing technology can be applied to solve for a rare genetic disease. If you have an interest or asset in #CysticFibrosis, #bronchiectasis, #PCD, Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) or other rare respiratory diseases, then join us on 1st October at The Francis Crick Institute. 💊 This event is for #biotech, #pharma and #investors with an interest in #rare and #orphandrugs across the continuum of development from #pipeline to #market launch. Network with leaders in #genomics, #translational medicine, #peadiatric respiratory research.

Missed Our Hot Topics in Employer Stop Loss Webinar? Watch it On-Demand! Did you miss our insightful webinar on the latest trends and challenges in employer stop loss? Don't worry—you can still catch up by watching the recording on-demand! In this presentation, you'll learn about: 🔹 The impact of COVID-19 on mortality and morbidity 🔹 Current medical trends affecting the general economy 🔹 Emerging insights into long COVID and its implications 🔹 The effects of Mental Health Parity on stop loss 🔹 Trends in specialty drugs and their impact 🔹 How cell and gene therapy are influencing stop loss 🔹 The effects of deductible leveraging in stop loss 🔹 The impact of accelerating large stop-loss claims on trends 🔹 A brief history of universal health care 🔹 What the future holds for employer stop loss This comprehensive webinar is packed with expert insights that will help you navigate the world of employer-stop loss and be able to anticipate future challenges. Don't miss this opportunity to stay informed and ahead of the curve. Watch the webinar on-demand now: https://lnkd.in/gGC4BviV #EmployerStopLoss #InsuranceTrends #HealthcareInnovation #Covid19Impact #SpecialtyDrugs #MentalHealthParity #StopLossClaims #TISInsurance

Interested in learning about trends, conversation, and innovations occurring in the viral vector-based therapy sector? Read what this panel of experts, including George Buchman, had to say at the ASGCT in the Medicine Maker Q&A article highlighting Catalent's CGT and viral vector expertise. #viralvector #genetherapy #advancedtherapies

Enjoyed my first time attending #CGMesa24 in PHX with Gina Black, MBA. Great to learn more about ongoing efforts to make cell and gene treatments further accessible (as thoughtfully as possible) to patients, physicians, and institutions across the board. We were fortunate enough to meet some incredibly smart and passionate people who were already hard at work on it. Charismatic speaker panels and moderators drove well-considered discussions with thoughtleaders from all stakeholders. There was also an incredible patient testomonial that was a stark reminder on how much extra room there is to enhance the patient experience. Looking forward to attending future events, from a market access viewpoint some topics really hit home: ⁃ Rethinking of patient journeys beyond traditional parameters ⁃ Downstream benefits of market access strategy 1-2 years ahead of PDUFA / prior to publication of pivotal study ⁃ Urgency to ease academic/community hospital burdens of all imagineable forms so they can instead focus on patient care (for example: product portals are necessary, and do work fine, but yet apparently are not a favorite thing?🙂)

The use of #moleculardiagnostics in #clinicalsettings leads to significant improvements in patient outcomes. By identifying specific genetic mutations or biomarkers, healthcare providers can tailor treatment plans to target the individual needs of each patient. This personalized approach can result in more effective therapies, reduced side effects, and ultimately better overall health and well-being for those undergoing treatment. Furthermore, molecular diagnostics can also help identify potential health risks before symptoms even develop, allowing for earlier intervention and prevention of disease progression. #healthcare #medicine #moleculartesting #omics #precisionmedicine

Autosomal Dominant Polycystic Kidney Disease Market is a genetic disorder affecting millions globally, characterized by the growth of numerous cysts in the kidneys. As awareness and diagnosis improve, the market for ADPKD treatments is expanding rapidly. 𝐊𝐞𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 : 𝐑𝐢𝐬𝐢𝐧𝐠 𝐈𝐧𝐜𝐢𝐝𝐞𝐧𝐜𝐞:Increased recognition and genetic testing drive demand for effective therapies. 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬: New drug developments, including targeted therapies, are on the rise, providing hope for better management. 𝐏𝐚𝐭𝐢𝐞𝐧𝐭-𝐂𝐞𝐧𝐭𝐫𝐢𝐜 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬: Focus on improving quality of life through personalized medicine. With ongoing research and collaboration, the future looks promising for patients and stakeholders in the ADPKD market. Get more on : https://lnkd.in/d2xYKy-f #ADPKD #HealthcareInnovation #MarketTrends #KidneyHealth

For the first time since 2020, US life expectancy has increased. Genflow Biosciences (LON:GENF) (OTCQB:GENFF) is dedicated to ensuring that #healthspan grows alongside lifespan. Our groundbreaking research surrounding #SIRT6 mutations could revolutionize how we age and ensure we live healthier for longer. Learn more about our research: https://loom.ly/uh0pGy8